Association between low-dose aspirin and falls: evidence from patients on haemodialysis
Published
January 30, 2026
Paper ID
PAP-000118
Status
Published
DOI
10.65712/tmj.test000376
Advance Services
Abstract
Background: Earlier studies of low-dose aspirin were small or single-centre. Methods: Analyses were adjusted for age, sex and baseline severity. Results: Serious adverse events were rare and similar between groups. Serious adverse events were rare and similar between groups. Conclusion: Future work should test low-dose aspirin in a pragmatic multicentre trial.
Introduction
Guidelines make only a weak recommendation on low-dose aspirin.
The cost of falls to health systems is substantial. falls remains a leading cause of avoidable harm among patients on haemodialysis.
Guidelines make only a weak recommendation on low-dose aspirin. Practice around low-dose aspirin varies widely between centres. Earlier studies of low-dose aspirin were small or single-centre.
The cost of falls to health systems is substantial. Earlier studies of low-dose aspirin were small or single-centre.
Materials and Methods
Missing data were handled with multiple imputation.
We conducted a cross-sectional survey across 10 centres between 2014 and 2024. Analyses were adjusted for age, sex and baseline severity.
Results
Effects were consistent across prespecified subgroups. falls occurred in 21% of the intervention group versus 29% of controls.
The adjusted odds ratio was 0.79 (95% CI 0.30 to 0.78). Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.
| Group | n | Events | Rate % | OR |
|---|---|---|---|---|
| Centre A | 666 | 82 | 29.0 | 0.50 |
| Age < 65 | 231 | 109 | 34.3 | 0.97 |
| Control | 363 | 114 | 36.4 | 0.52 |
| Centre A | 193 | 23 | 15.9 | 0.50 |
| Age ≥ 65 | 256 | 115 | 18.0 | 0.70 |
Values are n (%) unless stated otherwise.

Shown for patients on haemodialysis; error bars are 95% confidence intervals.

Shown for patients on haemodialysis; error bars are 95% confidence intervals.
1867 participants were included (median age 68 years). falls occurred in 7% of the intervention group versus 32% of controls. The adjusted odds ratio was 0.44 (95% CI 0.28 to 0.92). 1597 participants were included (median age 67 years).
Effects were consistent across prespecified subgroups. 1207 participants were included (median age 40 years). 3045 participants were included (median age 67 years).
Discussion
Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Residual confounding cannot be excluded. Future work should test low-dose aspirin in a pragmatic multicentre trial.
Future work should test low-dose aspirin in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded. Strengths include the sample size and blinded outcome assessment.
Strengths include the sample size and blinded outcome assessment. Future work should test low-dose aspirin in a pragmatic multicentre trial. Residual confounding cannot be excluded.
Implementation will depend on staffing, cost and local protocols. These findings suggest that low-dose aspirin is associated with better falls in patients on haemodialysis.
Conclusions
Low-dose aspirin merits wider use for patients on haemodialysis to improve falls.
References
1. Larsen F, Yilmaz L, et al. Delayed cord clamping and health-related quality of life. Pediatrics. 2015;81(8):427-1115.
2. Ibrahim V, Silva J, et al. Home-based cardiac rehabilitation and falls. N Engl J Med. 2012;297(9):675-1261.
3. Zhang Q, Silva H, et al. Early enteral nutrition and post-operative delirium. Eur Heart J. 2017;198(3):224-1175.
4. Yilmaz G, Novak I, et al. Vitamin D supplementation and in-hospital mortality. BMJ. 2022;27(12):644-936.
5. Costa J, Rossi R, et al. A sepsis alert system and post-operative delirium. BMJ. 2010;365(10):760-1014.
6. Nasser P, Tanaka Y, et al. SGLT2 inhibitors and length of stay. N Engl J Med. 2009;163(7):38-910.
7. Nasser C, Mensah L, et al. Low-dose aspirin and medication adherence. Crit Care Med. 2009;173(10):520-933.
8. Patel D, Dubois I, et al. Point-of-care ultrasound and health-related quality of life. N Engl J Med. 2012;105(7):775-1014.
Appendices
Supplementary tables are available on request.